Recombinant Human RNF6 Protein, N-His-SUMO

Introduction to Recombinant Human RNF6 Protein

Recombinant Human RNF6 Protein, also known as Ring Finger Protein 6, is a protein that plays a crucial role in various cellular processes such as cell growth, differentiation, and apoptosis. It is encoded by the RNF6 gene, located on chromosome X in humans. This protein belongs to the RING finger family of proteins, which are involved in ubiquitin-mediated protein degradation and regulation of signaling pathways.

Structure of Recombinant Human RNF6 Protein

The Recombinant Human RNF6 Protein is composed of 215 amino acids and has a molecular weight of approximately 24 kDa. It contains a conserved N-terminal RING finger domain, which is responsible for its E3 ubiquitin ligase activity. This domain is characterized by a cysteine-rich motif that binds to two zinc ions and is involved in the transfer of ubiquitin molecules to target proteins.

The RING finger domain is followed by a coiled-coil region, which is responsible for protein-protein interactions. This region also contains a nuclear localization signal, indicating the potential role of RNF6 in nuclear processes. The C-terminal region of the protein contains a proline-rich domain, which is involved in binding to SH3 domain-containing proteins and regulating cell signaling pathways.

Activity of Recombinant Human RNF6 Protein

Recombinant Human RNF6 Protein has been shown to have E3 ubiquitin ligase activity, which is essential for the regulation of protein degradation. It catalyzes the transfer of ubiquitin molecules to target proteins, marking them for degradation by the proteasome. This process is crucial for maintaining cellular homeostasis and regulating various signaling pathways.

Moreover, RNF6 has been found to interact with several proteins involved in cell growth and differentiation, such as SMAD4, p53, and TGF-β. It has also been shown to play a role in the regulation of androgen receptor signaling, which is important for prostate cancer progression.

Application of Recombinant Human RNF6 Protein

The use of Recombinant Human RNF6 Protein has been widely studied in various research fields, including cancer biology, cell signaling, and protein degradation. Its E3 ubiquitin ligase activity makes it a potential target for drug development, particularly in cancer therapy.

Studies have shown that RNF6 is overexpressed in several types of cancer, including prostate, breast, and lung cancer. Inhibition of RNF6 has been found to suppress tumor growth and sensitize cancer cells to chemotherapy. Therefore, targeting RNF6 could be a promising strategy for cancer treatment.

In addition, Recombinant Human RNF6 Protein has been used in studies investigating the role of RNF6 in cell signaling pathways. It has been shown to regulate the activity of SMAD4, a key mediator of TGF-β signaling, and p53, a tumor suppressor protein. Understanding the mechanisms of RNF6 in these pathways could lead to the development of novel therapies for diseases such as cancer and fibrosis.

Furthermore, the use of Recombinant Human RNF6 Protein in protein degradation studies has provided valuable insights into the regulation of cellular processes. Its E3 ubiquitin ligase activity has been utilized to study the degradation of specific target proteins and their role in various cellular functions.

Conclusion

Recombinant Human RNF6 Protein is a crucial protein involved in cellular processes such as cell growth, differentiation, and apoptosis. Its structure, E3 ubiquitin ligase activity, and interactions with other proteins make it a promising target for drug development and a valuable tool for studying cell signaling and protein degradation. Further research on the role of RNF6 in various diseases could lead to the development of novel therapies and treatments.